Open sidebar
Focus
nasal
Companies
|
Reuters
AstraZeneca’s COVID Vaccine Suffers a Setback in Nasal Spray Trial
Oct 12, 2022
|
Reuters
Twitter
Facebook
LinkedIn
Telegram
Email
Oct 12
|
Twitter
Facebook
LinkedIn
Telegram
Email